AstraZeneca outspent rivals Pfizer and Merck by 30% on consumer advertising for Crestor, helping the drug become the fastest-growing cholesterol treatment, Bloomberg.com reported.AstraZeneca spent ...
LONDON, June 8 (Reuters) - AstraZeneca Plc's key cholesterol drug Crestor has seen its market share growth in the United States stall, suggesting sales this year may struggle to meet forecasts, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results